Durvalumab vs Metronidazole

Durvalumab vs Metronidazole: Overview

This comparison examines the pharmacological differences between Durvalumab and Metronidazole.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Metronidazole — 8 hours.

Chemical Properties

Molecular Formula: Metronidazole — C6H9N3O3.

Molecular Weight: Metronidazole — 171.1540 g/mol.

Type: Durvalumab — Antibody; Metronidazole — Small molecule.